Rapidly boosted Plasma IL-5 induced by treatment of human Schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils

Research output: Contribution to journalJournal articleResearchpeer-review

  • Shona Wilson
  • Frances M. Jones
  • Hassan K. M. Fofana
  • Aissata Doucouré
  • Aly Landouré
  • Gachuhi Kimani
  • Joseph K. Mwatha
  • Moussa Sacko
  • Vennervald, Birgitte J
  • David W Dunne
IgE specific to worm antigen (SWA) and pre-treatment eosinophil number, are associated with human immunity to re-infection with schistosomes after chemotherapeutic treatment. Treatment significantly elevates circulating IL-5 24-hr post-treatment of Schistosoma mansoni. Here we investigate if praziquantel treatment of human schistosomiasis haematobium also boosts circulating IL-5, the immunological and parasitological factors that predispose to this, and the relationship between these and subsequent immunity to post-treatment re-infection.
Original languageEnglish
Article numbere2149
JournalP L o S Neglected Tropical Diseases (Online)
Volume7
Issue number3
Number of pages8
ISSN1935-2735
DOIs
Publication statusPublished - 2013

    Research areas

  • Adolescent, Adult, Animals, Anthelmintics, Antigens, Helminth, Child, Child, Preschool, Eosinophils, Female, Humans, Immunoglobulin E, Interleukin-5, Male, Plasma, Praziquantel, Schistosoma haematobium, Schistosomiasis haematobia, Young Adult

ID: 65707561